ConductScience.org, home

Trial · NCT04249336

Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH

NCT04249336, Phase 3, Completed, Dow University of Health Sciences; results first posted 2021-05-11

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH. Trials, record NCT04249336. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04249336

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Clinical Efficacy Of BioMin F, Colgate Sensitive Pro-Relief And Sensodyne Rapid Action Dentifrices In DH
NCT number
NCT04249336
Status
Completed
Phases
Phase 3
Enrollment
140 participants, actual
Lead sponsor
Dow University of Health Sciences
Conditions
Dentin Hypersensitivity
Interventions
Fluoro-Calcium-Phospho-Silicate based dentifrices, 8% Arginine based dentifrices, 8% Strontium Acetate, Sodium Fluoride
First posted
2020-01-30
Last updated
2021-05-11
Results first posted
2021-05-11

Source ClinicalTrials.gov

Registered outcomes3

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast Stimulus(Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)
SCHIFF cold air sensitivity scale was used to measure the intensity of pain due to dentin hypersensitivity using air blast stimulus. Patients' response of pain was assessed by the doctor according to following score range from; "0"(no response of pain), "1" (pain response but no request of discontinuity of stimulus), "2"(pain response with request of discontinuity of stimulus), "3"(Immediate pain response for discontinuity of stimulus). Percent change in mean scores = ( one minute score-Baseline score) / Baseline score
SecondaryPercent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Mechanical Stimulus(Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)
Visual Analogue Scale was used to measure the intensity of pain due to dentin hypersensitivity using mechanical stimulus. Patient's response of pain was assessed on vertical line of 0 to 10cm by asking him to move finger on the line and stop it where he felt pain. Score range from; 0 (no pain at 0cm), 1(mild pain at 1cm), 2(mild pain at 2cm), 3(mild pain at 3cm), 4(moderate pain at 4cm), 5(moderate pain at 5cm), 6(moderate pain at 6cm), 7(severe pain at 7cm), 8(severe pain at 8cm), 9(severe pain at 9cm),10(worst imaginable pain at 10cm). Percent change in mean scores = (one minute score-Baseline score) / Baseline score
SecondaryPercent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Water Jet Stimulus(Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)
Visual Analogue Scale was used to measure the intensity of pain due to dentin hypersensitivity using Water Jet Stimulus. Patient's response of pain was assessed on vertical line of 0 to 10cm by asking him to move finger on the line and stop it where he felt pain. Score range from; 0 (no pain at 0cm), 1(mild pain at 1cm), 2(mild pain at 2cm), 3(mild pain at 3cm), 4(moderate pain at 4cm), 5(moderate pain at 5cm), 6(moderate pain at 6cm), 7(severe pain at 7cm), 8(severe pain at 8cm), 9(severe pain at 9cm),10(worst imaginable pain at 10cm). Percent change in mean scores = (one minute score-Baseline score) / Baseline score

Outcomes3

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured as
PRIMARYPercent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast Stimulus(Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)
35 individuals per treatment group were recruited and enrolled in the study after clinical diagnosis of dentin hypersensitivity using air blast stimulus and SCHIFF cold air sensitivity scale. These participants were tested again for dentin hypersensitivity using mechanical stimulus and Visual Analogue Scale. After lost to follow up, statistical analysis was performed for 32 participants per group with baseline SCHIFF scale score of ≥2.
percentage of change in mean scoresMEAN
SECONDARYPercent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Mechanical Stimulus(Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)
35 individuals per treatment group were recruited and enrolled in the study after clinical diagnosis of dentin hypersensitivity using air blast stimulus and SCHIFF cold air sensitivity scale. These participants were tested again for dentin hypersensitivity using mechanical stimulus and Visual Analogue Scale. Statistical analysis was performed for 20 participants out of 32 per group with visual Analogue Scale score of ≥4.
percentage of change in mean scoresMEAN
SECONDARYPercent Change in Mean Scores of Pain Response From Baseline on Visual Analog Scale Using Water Jet Stimulus(Base line to 1 minute) (Base line to 5 minutes)(Base line to day 3)(Base line to week 4)
35 individuals per treatment group were recruited and enrolled in the study after clinical diagnosis of dentin hypersensitivity using air blast stimulus and SCHIFF cold air sensitivity scale. These participants were tested again for dentin hypersensitivity using water jet stimulus and Visual Analogue Scale. Statistical analysis was performed for 20 participants out of 32 with Visual Analogue Scale score of ≥4.
percentage of change in mean scoresMEAN

Results by group48

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusBioMin F1- minute18Standard Deviation 21percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusColgate Sensitive Pro Relief1- minute45Standard Deviation 24percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusSensodyne Rapid Action1- minute37Standard Deviation 27percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusColgate Total1- minute15Standard Deviation 22percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusBioMin F5-minutes27Standard Deviation 22percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusColgate Sensitive Pro Relief5-minutes56Standard Deviation 25percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusSensodyne Rapid Action5-minutes51Standard Deviation 28percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusColgate Total5-minutes19Standard Deviation 21percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusBioMin FDay-322Standard Deviation 22percentage of change in mean scores
Percent Change in Mean Score of Pain Response From Baseline on Schiff Cold Air Sensitivity Scale Using Air Blast StimulusColgate Sensitive Pro ReliefDay-324Standard Deviation 21percentage of change in mean scores

Participant flow20

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDColgate Sensitive Pro Relief35
Overall StudySTARTEDBioMin F35
Overall StudySTARTEDSensodyne Rapid Action35
Overall StudySTARTEDColgate Total35
Overall StudyPer Protocol Population Day 3Colgate Sensitive Pro Relief32
Overall StudyPer Protocol Population Day 3BioMin F32
Overall StudyPer Protocol Population Day 3Sensodyne Rapid Action32
Overall StudyPer Protocol Population Day 3Colgate Total32
Overall StudyPer Protocol Population Week 4Colgate Sensitive Pro Relief33
Overall StudyPer Protocol Population Week 4BioMin F35

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals12

The totals the trial posted for each group.

TotalGroupAffectedAt risk
Total, all-cause mortalityBioMin F Dentifrices035
Total, all-cause mortalityColgate Sensitive Pro Relief Trade Mark Dentifrices035
Total, all-cause mortalitySensodyne Rapid Action Trade Mark Dentifrices035
Total, all-cause mortalityColgate Total Trade Mark035
Total, other adverse eventsBioMin F Dentifrices035
Total, other adverse eventsColgate Sensitive Pro Relief Trade Mark Dentifrices035
Total, other adverse eventsSensodyne Rapid Action Trade Mark Dentifrices035
Total, other adverse eventsColgate Total Trade Mark035
Total, serious adverse eventsBioMin F Dentifrices035
Total, serious adverse eventsColgate Sensitive Pro Relief Trade Mark Dentifrices035

Papers3

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
28219674BACKGROUNDPubMed
30166822BACKGROUNDPubMed
34615511DERIVEDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04249336

GET https://conductscience.org/api/trials/v1/NCT04249336/results?page=2